Macquarie VIP Science and Technology Series

Macquarie VIP Science and Technology Series(formerly, Delaware Ivy VIP Science and Technology)

Key features

Investing at the intersection of innovation and quality

Seeking innovative opportunities across the broad market

Built on a six-decade firm legacy of technology investing expertise

Daily pricing as of 12/02/2024

NAV
$29.73
NAV 1-day net change
0.44
Max offer price
$29.73

Total net assets as of 10/31/2024

All share classes
$637.6 million

Overview

Series information
Inception date 04/04/1997
Dividends paid (if any) Annual
Series identifiers
CUSIP 46600H794

Benchmark

S&P North American Technology Sector Index (view definition)

Performance

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.

Total returns may reflect waivers and/or expense reimbursements by the manager and/or distributor (as applicable) for some or all of the periods shown. Performance would have been lower without such waivers and reimbursements.

Average annual total return as of month-end (10/31/2024)

Returns for less than one year are not annualized.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

Average annual total return as of quarter-end (09/30/2024)

Returns for less than one year are not annualized.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

Expense ratio

Gross
1.15%
Net
1.15%

The performance and expense ratio information shown represent the performance and fees as they relate to actual shares of the Series. These examples do not include any fees or sales charges imposed by the variable insurance contract for which the Series is an investment option. If they were included, your costs would be higher and performance would be lower. Investors should consult the contract prospectus or disclosure documents for more information.

Calendar year total returns @ NAV

Year
Annual return
Year
Annual return
2023
39.04%
2022
-31.83%
2021
15.17%
2020
35.36%
2019
49.48%
2018
-5.23%
2017
32.12%
2016
1.54%
2015
-2.88%
2014
2.91%

Portfolio

Portfolio characteristics as of 10/31/2024

Number of holdings
35
Market cap (median) Source: FactSet
$110.5 billion
Market cap (weighted average) Source: FactSet
$987.3 billion
Portfolio turnover (last fiscal year)
36%
Beta (relative to S&P North American Technology Sector TR Index) (view definition)
0.92
Annualized standard deviation, 3 years (view definition)
22.96

Portfolio composition as of 10/31/2024
Total may not equal 100% due to rounding.

Domestic equities
84.9%
International equities & depositary receipts
14.4%
Cash, cash equivalents and other assets
0.7%

Top 10 holdings as of 10/31/2024

Holdings are as of the date indicated and subject to change.

List may exclude cash and cash equivalents. Please see the Series' complete list of holdings for more information.

Holdings based by issuer.

Holding
% of portfolio
Holding
% of portfolio
META PLATFORMS INC
10.02
NVIDIA CORPORATION
8.94
MICROSOFT CORPORATION
7.04
BROADCOM INC
5.64
SEAGATE TECHNOLOGY UNLIMITED CO
5.58
ZEBRA TECHNOLOGIES CORPORATION
5.05
AMAZON.COM INC
4.72
TAIWAN SEMICONDUCTOR MANUFACTURING CO LT
4.06
SAP SE
3.82
CADENCE DESIGN SYSTEMS INC
3.08

Total % Portfolio in Top 10 holdings - 57.95%

List of monthly holdingsList of quarterly holdings

Sector allocation as of 10/31/2024

List may exclude cash, cash equivalents, and exchange-traded funds (ETFs) that are used for cash management purposes. Please see the Series’ complete list of holdings for more information.

Sector
% of portfolio
Sector
% of portfolio
Information technology
66.3%
Communication services
13.8%
Consumer discretionary
10.1%
Healthcare
5.7%
Industrials
3.4%

Management

Gus C Zinn

Gus C. Zinn, CFA

  • Managing Director, Senior Portfolio Manager
  • Start date on the Fund: November 2021
  • Years of industry experience: 26
  • Read bio
Bradley J Warden

Bradley Warden, CFA

  • Managing Director, Senior Portfolio Manager
  • Start date on the Fund: October 2016
  • Years of industry experience: 27
  • Read bio

Fees

Annual portfolio operating expenses
Management fees 0.85%
Distribution and service (12b-1) fees 0.25%
Other expenses 0.05%
Total annual series operating expenses 1.15%

Please see the prospectus and SAI for additional information.

1Other expenses contain a 0.01% acquired fund fees and expenses. Acquired fund fees and expenses sets forth the Series' pro rata portion of the cumulative expenses charged by the registered investment companies (RICs) in which the Series invested during the last fiscal year. The actual Acquired fund fees and expenses will vary with changes in the allocations of the Series' assets. The Acquired fund fees and expenses shown are based on the total expense ratio of the RICs for the RICs' most recent fiscal period. These expenses are not direct costs paid by Series shareholders, and are not used to calculate the Series' NAV.

1The Fund’s investment manager, Delaware Management Company (Manager), has contractually agreed to waive all or a portion of its investment advisory fees and/or pay/reimburse expenses (excluding any acquired fund fees and expenses, taxes, interest, short sale dividend and interest expenses, brokerage fees, certain insurance costs, and nonroutine expenses or costs, including, but not limited to, those relating to reorganizations, litigation, conducting shareholder meetings, and liquidations) in order to prevent total annual fund operating expenses from exceeding 0.91% of the Fund’s average daily net assets from April 30, 2021 through April 30, 2022. These waivers and reimbursements may only be terminated by agreement of the Manager and the Fund.

Resources

Effective May 1, 2024, Class I was renamed Standard Class and Class II was renamed Service Class.

Carefully consider the Series' investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Series' prospectus and its summary prospectus, which may be obtained by visiting delawarefunds.com/vip-literature or calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.

The Series' investment manager, Delaware Management Company (Manager), may permit its affiliate, Macquarie Investment Management Global Limited (MIMGL), to execute Series security trades on behalf of the Manager. The Manager may also seek quantitative support from MIMGL.

Investing involves risk, including the possible loss of principal.

Because the Series invests more than 25% of its total assets in the energy related industry, the Series may be more susceptible to a single economic, regulatory, or technological occurrence than a portfolio that does not concentrate its investments in this industry. Investing in companies involved in one specified sector may be more risky and volatile than an investment with greater diversification.

“Non-diversified” investments may allocate more of their net assets to investments in single securities than “diversified” investments. Resulting adverse effects may subject these investments to greater risks and volatility.

Investment risks associated with investing in science and technology securities, in addition to other risks, include: operating in rapidly changing fields, abrupt or erratic market movements, limited product lines, markets or financial resources, management that is dependent on a limited number of people, short product cycles, aggressive pricing of products and services, new market entrants and obsolescence of existing technology.

Natural or environmental disasters, such as earthquakes, fires, floods, hurricanes, tsunamis, and other severe weather-related phenomena generally, and widespread disease, including pandemics and epidemics, have been and can be highly disruptive to economies and markets, adversely impacting individual companies, sectors, industries, markets, currencies, interest and inflation rates, credit ratings, investor sentiment, and other factors affecting the value of the Portfolio’s investments. Given the increasing interdependence among global economies and markets, conditions in one country, market, or region are increasingly likely to adversely affect markets, issuers, and/or foreign exchange rates in other countries. These disruptions could prevent the Portfolio from executing advantageous investment decisions in a timely manner and could negatively impact the Portfolio’s ability to achieve its investment objective. Any such event(s) could have a significant adverse impact on the value and risk profile of the Portfolio.

All third-party marks cited are the property of their respective owners.

Macquarie VIP funds are not available for direct investment except for issuers of variable insurance product contracts. They are available only through the purchase of certain variable insurance products.

Nothing presented should be construed as a recommendation to purchase or sell any security or follow any investment technique or strategy.

You can check the background of your investment professional on FINRA's BrokerCheck.